To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3316-3319. doi: 10.1007/s00259-022-05841-6.

Murat Tuncel^{1

2}, Alexis Vrachimis^{3

4}, Alfredo Campenni^{3

5}, Bart de Keizer^{3

6}, Frederik A Verburg⁷, Michael C Kreissl^{3

8}, Petra Petranovic Ovcaricek^{3

9}, Tamara Geliashvili^{3

10}, Luca Giovanella^{3

11}

¹ EANM Thyroid Committee, Vienna, Austria. muratmtx@yahoo.com.
² Department of Nuclear Medicine, Hacettepe University, Ankara, Turkey. muratmtx@yahoo.com.
³ EANM Thyroid Committee, Vienna, Austria.
⁴ Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
⁵ Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, Messina, Italy.
⁶ Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands.
⁷ Departments of Radiology and Nuclear Medicine, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, Netherlands.
⁸ Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Otto-Von-Guericke University, Magdeburg, Germany.
⁹ Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
¹⁰ Department of Radionuclide Therapy, Research Institute of Clinical and Experimental Radiology of the N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
¹¹ Clinic for Nuclear Medicine, Ente Ospedaliero Cantonale, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.

No abstract available

Publication types